Healthcare
AI in life sciences market forecast to reach USD 69.34 billion by 2031
A new industry forecast projects rapid expansion of AI across life sciences, including research, diagnostics and drug-development workflows.
MarketsandMarkets projects that the global AI-in-life-sciences market will grow from USD 21.58 billion in 2026 to USD 69.34 billion by 2031, at a compound annual growth rate of 26.3%. The forecast covers AI applications across life sciences, a sector closely connected to healthcare through drug discovery, clinical development, diagnostics and research. The report is a market outlook rather than a report of one specific technology deployment or clinical result. Its significance is that it quantifies the expected expansion of AI investment across the healthcare innovation pipeline. AI can support the analysis of large biological datasets, identification of drug candidates and optimization of research workflows, although the source excerpt does not provide details on specific companies or products driving the projection. The projected growth also indicates that adoption is moving beyond experimental pilots toward broader commercial activity. For healthcare organizations and life-sciences companies, this trend can increase demand for data scientists, validated platforms, secure computing and regulatory expertise. The forecast should still be distinguished from realized benefits: market growth does not by itself establish clinical effectiveness or patient outcomes.
Original source: GlobeNewswire